Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

All Drugs for Hepatocellular carcinoma (Page 2)

130 drugs are used for Hepatocellular carcinoma.

Drug Brand Name Reports Deaths Hosp.
PACLITAXEL PACLITAXEL PACLITAXEL 18 12,030 31,638
GADOXETATE EOVIST 16 12 72
LOBAPLATIN - 16 8 88
GELATIN - 14 10 20
IRINOTECAN Irinotecan Hydrochloride 14 4,530 10,384
OMBITASVIR\PARITAPREVIR\RITONAVIR - 14 557 2,664
DASABUVIR - 13 501 2,265
ENZALUTAMIDE Xtandi 13 9,676 9,282
NELVUTAMIG - 13 34 109
POLYVINYL ALCOHOL MINIDROPS 13 6 7
REGORAFENIB\REGORAFENIB - 13 32 39
10-HYDROXYCAMPTOTHECIN - 12 5 1
CYCLOPHOSPHAMIDE Cyclophosphamide 11 25,330 45,054
DEXAMETHASONE Dexamethasone Sodium Phosphate 11 22,319 51,311
ENTECAVIR Entecavir 11 726 1,133
PIRARUBICIN - 11 143 628
PONATINIB Iclusig 11 2,924 4,254
ZOLEDRONIC ACID Zoledronic acid 11 5,240 8,346
ETOPOSIDE Avopef 10 11,780 17,699
SUNITINIB MALATE Sunitinib malate 10 6,028 5,720
VINCRISTINE VinCRIStine Sulfate 10 14,548 26,911
IVUXOLIMAB - 9 0 14
OLAPARIB Lynparza 9 5,496 3,471
QUAVONLIMAB - 9 23 346
RITUXIMAB Rituxan 9 28,910 54,631
TACROLIMUS Tacrolimus 9 14,642 36,664
TPST-1120 - 9 0 8
DURVALUMAB\TREMELIMUMAB - 8 5 10
OCTREOTIDE Octreotide Acetate 8 5,003 7,779
PEGFILGRASTIM ZIEXTENZO 8 2,367 7,050
RIVOCERANIB - 8 5 32
TOCILIZUMAB Tocilizumab-anoh 8 9,543 24,039
BELZUTIFAN WELIREG 7 82 550
DAPAGLIFLOZIN QTERN 7 3,633 8,467
E-7386 - 7 2 17
INTERFERON ALFA-2A OR INTERFERON ALFA-2B - 7 61 134
LEDIPASVIR\SOFOSBUVIR - 7 1,371 4,031
LENALIDOMIDE LENALIDOMIDE 7 35,942 86,495
NINTEDANIB - 7 5,822 9,433
PALBOCICLIB Ibrance 7 11,066 13,442
PRAVASTATIN Pravastatin Sodium 7 923 2,338
THALIDOMIDE Thalomid 7 3,085 4,632
APATINIB - 6 25 42
AVELUMAB BAVENCIO 6 861 1,630
BEVACIZUMAB-ADCD - 6 15 24
CAPMATINIB TABRECTA 6 583 388
CEMIPLIMAB LIBTAYO 6 175 651
DOCETAXEL Docetaxel 6 6,068 13,463
IDARUBICIN Idamycin PFS 6 1,260 1,856
IOHEXOL Iohexol 6 298 1,604
« 1 2 3 »